CA2259724C - Anticorps monoclonal specifique du facteur v11 de la coagulation active et son utilisation - Google Patents
Anticorps monoclonal specifique du facteur v11 de la coagulation active et son utilisation Download PDFInfo
- Publication number
- CA2259724C CA2259724C CA2259724A CA2259724A CA2259724C CA 2259724 C CA2259724 C CA 2259724C CA 2259724 A CA2259724 A CA 2259724A CA 2259724 A CA2259724 A CA 2259724A CA 2259724 C CA2259724 C CA 2259724C
- Authority
- CA
- Canada
- Prior art keywords
- monoclonal antibody
- factor vii
- activated factor
- activated
- factor vll
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6437—Coagulation factor VIIa (3.4.21.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
- G01N2333/755—Factors VIII, e.g. factor VIII C [AHF], factor VIII Ag [VWF]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19802139A DE19802139C1 (de) | 1998-01-22 | 1998-01-22 | Monoklonaler Antikörper spezifisch für aktivierten Gerinnungsfaktor VII und seine Verwendung |
DEP19802139.9 | 1998-01-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2259724A1 CA2259724A1 (fr) | 1999-07-22 |
CA2259724C true CA2259724C (fr) | 2010-07-13 |
Family
ID=7855234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2259724A Expired - Fee Related CA2259724C (fr) | 1998-01-22 | 1999-01-20 | Anticorps monoclonal specifique du facteur v11 de la coagulation active et son utilisation |
Country Status (9)
Country | Link |
---|---|
US (2) | US6479245B1 (fr) |
EP (1) | EP0931793B1 (fr) |
JP (1) | JP4422228B2 (fr) |
KR (1) | KR100583537B1 (fr) |
AT (1) | ATE261991T1 (fr) |
AU (1) | AU742631B2 (fr) |
CA (1) | CA2259724C (fr) |
DE (2) | DE19802139C1 (fr) |
ES (1) | ES2217492T3 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19802139C1 (de) * | 1998-01-22 | 1999-09-23 | Centeon Pharma Gmbh | Monoklonaler Antikörper spezifisch für aktivierten Gerinnungsfaktor VII und seine Verwendung |
JP4309656B2 (ja) * | 2000-12-14 | 2009-08-05 | ジェネンテック・インコーポレーテッド | 原核生物で生成させた抗体とその用途 |
WO2003004694A1 (fr) * | 2001-07-03 | 2003-01-16 | Oklahoma Medical Research Foundation | Analyse destinee a mesurer les complexes facteur viia-antithrombine |
AU2020259982A1 (en) | 2019-04-17 | 2021-10-28 | Novo Nordisk A/S | Bispecific antibodies |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5843442A (en) * | 1990-10-22 | 1998-12-01 | Corvas International, Inc. | Blood coagulation protein antagonists and uses therefor |
US5506134A (en) * | 1990-10-22 | 1996-04-09 | Corvas International, Inc. | Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex |
MX9204374A (es) * | 1991-07-25 | 1993-03-01 | Idec Pharma Corp | Anticuerpo recombinante y metodo para su produccion. |
MA24512A1 (fr) * | 1996-01-17 | 1998-12-31 | Univ Vermont And State Agrienl | Procede pour la preparation d'agents anticoagulants utiles dans le traitement de la thrombose |
DE19802139C1 (de) * | 1998-01-22 | 1999-09-23 | Centeon Pharma Gmbh | Monoklonaler Antikörper spezifisch für aktivierten Gerinnungsfaktor VII und seine Verwendung |
-
1998
- 1998-01-22 DE DE19802139A patent/DE19802139C1/de not_active Expired - Fee Related
- 1998-12-24 DE DE59810998T patent/DE59810998D1/de not_active Expired - Lifetime
- 1998-12-24 EP EP98124672A patent/EP0931793B1/fr not_active Expired - Lifetime
- 1998-12-24 AT AT98124672T patent/ATE261991T1/de active
- 1998-12-24 ES ES98124672T patent/ES2217492T3/es not_active Expired - Lifetime
-
1999
- 1999-01-20 CA CA2259724A patent/CA2259724C/fr not_active Expired - Fee Related
- 1999-01-21 AU AU13185/99A patent/AU742631B2/en not_active Ceased
- 1999-01-21 US US09/234,504 patent/US6479245B1/en not_active Expired - Lifetime
- 1999-01-21 KR KR1019990001775A patent/KR100583537B1/ko not_active IP Right Cessation
- 1999-01-21 JP JP01261099A patent/JP4422228B2/ja not_active Expired - Fee Related
-
2002
- 2002-08-23 US US10/226,118 patent/US6835817B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP4422228B2 (ja) | 2010-02-24 |
DE19802139C1 (de) | 1999-09-23 |
DE59810998D1 (de) | 2004-04-22 |
AU1318599A (en) | 1999-08-12 |
JPH11279199A (ja) | 1999-10-12 |
ATE261991T1 (de) | 2004-04-15 |
ES2217492T3 (es) | 2004-11-01 |
US20030003096A1 (en) | 2003-01-02 |
AU742631B2 (en) | 2002-01-10 |
CA2259724A1 (fr) | 1999-07-22 |
KR19990068047A (ko) | 1999-08-25 |
US6835817B2 (en) | 2004-12-28 |
EP0931793A1 (fr) | 1999-07-28 |
EP0931793B1 (fr) | 2004-03-17 |
KR100583537B1 (ko) | 2006-05-26 |
US6479245B1 (en) | 2002-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4902614A (en) | Monoclonal antibody to human protein C | |
EP0528525B1 (fr) | Procédé et compositions pour détecter des protéases sanguines, spécialement pour protéine C activée | |
KR940002033B1 (ko) | 단백질 c에 대해 특이성이 있는 단클론성 항체 및 항체의 분리방법 | |
EP0162078B1 (fr) | Procede d'isolation d'une proteine d'un melange la contenant et un anticorps specifique de conformation | |
KR100202773B1 (ko) | 프로트롬빈 활성화 펩타이드 및 그것의 분해생성물에 대한 모노클론 항체 및 면역 분석법 | |
Kumar et al. | Identification of molecular sites on factor VII which mediate its assembly and function in the extrinsic pathway activation complex. | |
CA2259724C (fr) | Anticorps monoclonal specifique du facteur v11 de la coagulation active et son utilisation | |
AU621823B2 (en) | Improvements relating to measurement of tissue plasminogen activator activity | |
JP4398648B2 (ja) | 血液凝固第vii因子活性化プロテアーゼに対する抑制性モノクローナル抗体 | |
EP0339302B1 (fr) | Système de réactif pour essai immunologique du complexe de l'inhibiteur d'activeur plasminogène humain et de l'activeur plasminogène humain de tissu et trousse à cet effet | |
EP0192675B1 (fr) | Anticorps monoclonal anti-urokinase; production et utilisation | |
EP0205046B1 (fr) | Anticorps monoclonal contre la protéine C humaine | |
US6258938B1 (en) | Method for the purification and isolation of blood clotting proteins using conformation specific antibodies | |
EP0169549A2 (fr) | Détermination immunologique d'inhibiteur de plasmine/alpha-2-plasmine humain | |
CA1291424C (fr) | Methode faisant appel a un immunosorbant-amidolytique pour la detection du precurseur de l'activateur du plasminogene urinaire (pro-upa) et de l'activateur du plasminogene urinaire (u-pa) | |
JPH03200066A (ja) | 活性化ヒトプロテインcの測定方法 | |
US20040161810A1 (en) | Monoclonal antibodies specific for latent antithrombin III and the use thereof | |
JPH0260267B2 (fr) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20170120 |